Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDI Study of Ginkgolides Meglumine Injection and Midazolam
NCT02233972Phase 4Completed
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Aug 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Ginkgo diterpene lactone meglumine in ischemic stroke, sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Aug 2014; status: completed.
02
Drugs
Ginkgo diterpene lactone meglumine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02233972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02233972.